These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25487944)

  • 1. Effects of polyunsaturated fatty acids on endometrial carcinoma Ishikawa cells.
    Lu XY; Zeng T
    Eur Rev Med Pharmacol Sci; 2014; 18(21):3311-4. PubMed ID: 25487944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Mechanism of Action of Different ω-6/ω-3 Polyunsaturated Fatty Acids Ratio on the Growth of Endometrial Carcinoma Mice.
    Lu X; Ding X; Jing L
    Cell Biochem Biophys; 2015 Apr; 71(3):1671-6. PubMed ID: 25534488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
    Zhuo Z; Yu H
    Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y; Wang C; Yang H; Ma X
    Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling.
    Quan P; Moinfar F; Kufferath I; Absenger M; Kueznik T; Denk H; Zatloukal K; Haybaeck J
    Anticancer Res; 2014 Jun; 34(6):2883-97. PubMed ID: 24922651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin is associated with reduced cell proliferation in human endometrial cancer by inbibiting PI3K/AKT/mTOR signaling.
    Zhao Y; Sun H; Feng M; Zhao J; Zhao X; Wan Q; Cai D
    Gynecol Endocrinol; 2018 May; 34(5):428-432. PubMed ID: 29182407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
    Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic in vitro anti-tumor effect of letrozole and everolimus on human endometrial carcinoma Ishikawa cells.
    Lu XY; Yang Y; Xu H; Zeng T; Zhang ZZ
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2264-9. PubMed ID: 25219824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
    Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
    Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1alpha in endometrial carcinoma cells with expression of suppressor endoprotein PTEN.
    Li XP; Zhao D; Gao M; Zhao C; Wang JL; Wei LH
    Chin Med J (Engl); 2006 Mar; 119(5):378-83. PubMed ID: 16542580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of endometrial cancer by n-3 polyunsaturated fatty acids in preclinical models.
    Zheng H; Tang H; Liu M; He M; Lai P; Dong H; Lin J; Jia C; Zhong M; Dai Y; Bai X; Wang L
    Cancer Prev Res (Phila); 2014 Aug; 7(8):824-34. PubMed ID: 24866178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
    Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
    Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
    Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
    Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.
    Schrauwen S; Depreeuw J; Coenegrachts L; Hermans E; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Jul; 138(1):165-73. PubMed ID: 25933683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of PDCD4 induced by progesterone is mediated by the PI3K/AKT signaling pathway in human endometrial cancer cells.
    Wang X; Li Y; Wan L; Liu Y; Sun Y; Liu Y; Shi Y; Zhang L; Zhou H; Wang J; Wang X; Wei Z
    Oncol Rep; 2019 Aug; 42(2):849-856. PubMed ID: 31233196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-Derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women.
    Sahoo SS; Lombard JM; Ius Y; O'Sullivan R; Wood LG; Nahar P; Jaaback K; Tanwar PS
    Mol Cancer Res; 2018 Feb; 16(2):309-321. PubMed ID: 29133593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A marine sponge alkaloid derivative 4-chloro fascaplysin inhibits tumor growth and VEGF mediated angiogenesis by disrupting PI3K/Akt/mTOR signaling cascade.
    Sharma S; Guru SK; Manda S; Kumar A; Mintoo MJ; Prasad VD; Sharma PR; Mondhe DM; Bharate SB; Bhushan S
    Chem Biol Interact; 2017 Sep; 275():47-60. PubMed ID: 28756150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.
    Slomovitz BM; Coleman RL
    Clin Cancer Res; 2012 Nov; 18(21):5856-64. PubMed ID: 23082003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.